When Apple released iOS 18.6.1 and watchOS 11.6.1 last week, bringing Blood Oxygen monitoring to previously excluded models following a U.S. Customs and Border Protection approval that allowed Apple to move forward with the “redesigned” experience on those devices, we had a gut feeling that patent troll Masimo wouldn’t let that go very far without a fight.
Apple announced on Thursday that it would release iOS 18.6.1 for iPhones and watchOS 11.6.1 for Apple Watches so that Blood Oxygen monitoring could make a comeback on certain models – specifically, the Apple Watch Series 9, Series 10, and Ultra 2.
Apple urged the United States Cort of Appeals on Monday, July 7th to overturn a damaging 2023 International Trade Commission (ITC) ruling that required the Cupertino-based company to strip blood-oxygen monitoring features from its Apple Watch wearable fitness devices to evade a total import ban on the devices by regulators.
Apple has reportedly disabled blood oxygen sensing in the Apple Watch Series 9 and Ultra 2 on newly imported units to work around the ITC's import ban.
Health accessory maker Withings, well-known for their HealthKit-compatible smart scales and vital-tracking devices, is taking advantage of CES to showcase their latest step forward in helping people manage their health.
The Apple Watch provides a pair of health-tracking features that measure your heart rate and heart rhythm, each officially cleared by the United States Food and Drug Administration (FDA). However, blood oxygen monitoring that's available on the new Apple Watch Series 6 model doesn't need a clearance from the FDA, and here's why.
Apple today unveiled the new Apple Watch Series 6 models and one of the biggest features is the ability to measure your blood oxygen saturation. Here's how it works.